Twenty-seven states and the District of Columbia have sued the bankrupt genetic testing company 23andMe in an effort to block ...

States argue that biological samples, DNA data, health-related traits and medical records are too sensitive to be sold ...

The possible sale of 23andMe’s genetic data could set a precedent for future cases where companies look to offload ...

Twenty-seven states and Washington, D.C., have filed a lawsuit to block the sale of customers’ DNA and data without their ...

New York and more than two dozen other US states sued 23andMe to challenge the sale of its customers’ private information after the genetic testing company filed for bankruptcy in March.

D.C. sue to block 23andMe's data sale amid bankruptcy proceedings. Regeneron Pharmaceuticals' $256 million acquisition faces ...

People did not submit their personal data to 23andMe thinking their genetic blueprint would later be sold off to the highest ...

Twenty-eight states argue that 23andMe must secure explicit, informed consent from all 15 million affected users before ...

The states argue that customers should have control over their personal information, which cannot be treated like ordinary ...

Dozens of States Sue to Block the Sale of 23andMe Personal Genetic Data Without Customer Consent PORTLAND, Ore. (AP) — Twenty-seven states and the District of Columbia on Monday filed a lawsuit ...

PORTLAND, Ore. — Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer ...